Skip to main contentSkip to navigation
Sirius Investors
Nascent Biotech, Inc.

Nascent Biotech, Inc.

NBIO
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for NBIO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
28.04M
173.9x increase over period
CAGR: +59.78%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
27.79M
88.9x increase over period
CAGR: +50.33%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Sep 30, 2024

EV/EBITDA

Distorted

-32.40x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-249.62K

EV is -0.9% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -94.7 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: -0.23x

Share count change in dataset: +5696.43%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Mar 31, 202428.04M27.79M$0.18155.75M
Mar 31, 20236.67M6.89M$0.06118.57M
Mar 31, 20226.14M6.05M$0.06107.74M
Mar 31, 2021
Mar 31, 2020
Mar 31, 2019
Mar 31, 2018
Mar 31, 2017
Mar 31, 2016
Mar 31, 2015
Mar 31, 2014
Mar 31, 2013

Enterprise Value Analysis

Price Change (Mar 2023 to Mar 2024)

The stock price has increased from Mar 2023 to Mar 2024.
+220.00%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
1.12

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.30

Market Cap Change (Mar 2023 to Mar 2024)

The company's market capitalization has increased from Mar 2023 to Mar 2024.
+320.35%

Enterprise Value Change (Mar 2023 to Mar 2024)

The company's enterprise value has increased from Mar 2023 to Mar 2024, suggesting growth in the company's total economic value.
+303.45%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (12 periods), accounting for compounding effects.
59.78%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (12 periods), accounting for compounding effects.
50.33%